SCHEMBL4748270

SCHEMBL4748270

N[C@@H](Cc1ccccc1)C(=O)OP(N)(=O)O

nearest known ligand 0.56

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALPI P09923 1/20 0.56
PKM P14618 1/20 0.56
PTGS1 P23219 1/20 0.56
XIAP P98170 1/20 0.56
SLC7A5 Q01650 1/20 0.56
LAP3 P28838 5/20 0.53
ANPEP P15144 3/20 0.53
SLC15A1 P46059 2/20 0.49
LTA4H P09960 1/20 0.46
PTPN1 P18031 1/20 0.46
SLC1A3 P43003 2/20 0.45
SLC1A2 P43004 2/20 0.45
SLC1A1 P43005 2/20 0.45
ERAP2 Q6P179 1/20 0.44
HDAC8 Q9BY41 1/20 0.44
SRR Q9GZT4 1/20 0.44
ACP3 P15309 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29761129 1.00 ALPI (0.56) ALPIPKMPTGS1XIAPSLC7A5
Phosphoramidic Acid SCHEMBL13858640 0.98 ALPI (0.54) ALPIPKMPTGS1XIAPSLC7A5
Phosphoramidic Acid SCHEMBL1691253 0.98 ALPI (0.54) ALPIPKMPTGS1XIAPSLC7A5
SCHEMBL4748271 0.89 ALPI (0.58) ALPIPKMPTGS1XIAPSLC7A5
SCHEMBL4748266 0.89 ALPI (0.58) ALPIPKMPTGS1XIAPSLC7A5
SCHEMBL4958184 0.89 ALPI (0.58) ALPIPKMPTGS1XIAPSLC7A5
SCHEMBL7868422 0.84 ALPI (0.53) ALPIPKMPTGS1XIAPSLC7A5
SCHEMBL8610212 0.84 ALPI (0.56) ALPIPKMPTGS1XIAPSLC7A5
SCHEMBL19658097 0.83 LAP3 (0.57) ALPIPKMPTGS1XIAPSLC7A5
SCHEMBL7532724 0.82 ALPI (0.50) ALPIPKMPTGS1XIAPSLC7A5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012142388-A2 METHODS, COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR TREATING ANXIETY AND MOOD DISORDERS NEW YORK UNIVERSITY (US) 2012-10-18 WO claimed
EP-1150988-B1 PHOSPHORAMIDATE, AND MONO-, DI-, AND TRI-PHOSPHATE ESTERS OF (1R, CIS)-4-(6-AMINO-9H-PURIN-9-YL)-2-CYCLOPENTENE-1-METHANOL AS ANTIVIRAL AGENTS GLAXO GROUP LTD (GB) 2003-05-28 EP claimed
WO-2015009897-A1 COMPOSITIONS AND METHODS FOR PRESERVING RED BLOOD CELLS AND PLATELETS RYTHRX THERAPEUTICS, LLC (US) 2015-01-22 WO disclosed
WO-2008121941-A1 PRODRUGS OF TRICIRIBINE AND TRICIRIBINE PHOSPHATE TSRL, INC. (US) 2008-10-09 WO disclosed